MCID: SBR001
MIFTS: 34

Seborrheic Infantile Dermatitis

Categories: Immune diseases, Skin diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Seborrheic Infantile Dermatitis

MalaCards integrated aliases for Seborrheic Infantile Dermatitis:

Name: Seborrheic Infantile Dermatitis 11 14 16
Cradle Cap 11 71 75 33
Infantile Seborrhoeic Dermatitis 11 33
Seborrhoeic Eczema of Scalp 11 33
Seborrhoea Capitis 11 31
Infantile Seborrhoeic Dermatitis of the Scalp 33
Generalized Seborrheic Dermatitis of Infants 11
Complement Component 5 Deficiency 71
Seborrheic Dermatitis of Infancy 33
Infantile Seborrheic Dermatitis 11
Seborrhoeic Dermatitis of Scalp 11
Neonatal Seborrhoeic Dermatitis 33
Seborrheic Dermatitis of Scalp 71
Infantile Seborrhoeic Eczema 33
Complement 5 Dysfunction 11
Seborrheic Dermatitis 71
Scurfiness of Scalp 71
Pityriasis Capitis 11
Seborrhea Capitis 11
Seborrhea Sicca 11
Dandruff 43

Classifications:



External Ids:

Disease Ontology 11 DOID:8941
ICD9CM 34 690.11
MeSH 43 D063807
SNOMED-CT 68 48596006
ICD10 31 L21.0 L21.1
UMLS 71 C0036508 C0221244 C0263233 more

Summaries for Seborrheic Infantile Dermatitis

Disease Ontology: 11 A seborrheic dermatitis that involves fungal infection of the scalp of recently born babies caused by Malassezia furfur. It is occasionally linked to immune disorders. The symptoms include thick, crusty, yellow or brown scales over the child's scalp.

MalaCards based summary: Seborrheic Infantile Dermatitis, also known as cradle cap, is related to seborrheic dermatitis and dermatitis. An important gene associated with Seborrheic Infantile Dermatitis is DOP1B (DOP1 Leucine Zipper Like Protein B). The drugs Ciclopirox and Ketoconazole have been mentioned in the context of this disorder. Affiliated tissues include skin and liver.

Wikipedia: 75 Cradle cap or cradle hat causes crusty or oily scaly patches on a baby's scalp. The condition is not... more...

Related Diseases for Seborrheic Infantile Dermatitis

Diseases in the Seborrheic Dermatitis family:

Seborrheic Infantile Dermatitis

Diseases related to Seborrheic Infantile Dermatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 50)
# Related Disease Score Top Affiliating Genes
1 seborrheic dermatitis 31.1 ZNF750 MPZL3 FLG
2 dermatitis 10.4
3 anterior cutaneous nerve entrapment syndrome 10.2
4 skin disease 10.2
5 ichthyosis with confetti 10.2
6 alopecia 10.1
7 pyoderma 10.1
8 acne 10.1
9 fanconi anemia, complementation group e 10.1
10 superficial mycosis 10.1
11 ige responsiveness, atopic 10.0
12 herpes simplex 10.0
13 eczema herpeticum 10.0
14 dermatitis, atopic 10.0
15 dermatitis, atopic, 2 10.0
16 exanthem 10.0
17 tinea pedis 10.0
18 scalp dermatosis 10.0
19 tinea capitis 10.0
20 dermatophytosis 10.0
21 asthma 10.0
22 pityriasis versicolor 10.0
23 blepharitis 10.0
24 alopecia, androgenetic, 1 9.9
25 papillomatosis, confluent and reticulated 9.9
26 psoriasis 1 9.9
27 trichohepatoenteric syndrome 1 9.9
28 suppressor of tumorigenicity 11 9.9
29 psoriasis 2 9.9
30 psoriasis 7 9.9
31 psoriasis 11 9.9
32 psoriasis 13 9.9
33 androgenic alopecia 9.9
34 allergic disease 9.9
35 fungal infectious disease 9.9
36 telogen effluvium 9.9
37 contact dermatitis 9.9
38 breast adenocarcinoma 9.9
39 folliculitis 9.9
40 psoriasis 9.9
41 alopecia areata 9.9
42 demodicidosis 9.9
43 primary agammaglobulinemia 9.9
44 chronic bilirubin encephalopathy 9.9
45 ichthyosis, x-linked 9.7 PNPLA1 FLG
46 ichthyosis vulgaris 9.6 PNPLA1 FLG
47 ichthyosis, congenital, autosomal recessive 4b 9.6 PNPLA1 FLG CST6
48 ichthyosis 9.5 PNPLA1 FLG CST6
49 autosomal recessive congenital ichthyosis 9.5 PNPLA1 FLG CST6
50 epidermolytic hyperkeratosis 9.5 PNPLA1 FLG

Comorbidity relations with Seborrheic Infantile Dermatitis via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Seborrheic Infantile Dermatitis:



Diseases related to Seborrheic Infantile Dermatitis

Symptoms & Phenotypes for Seborrheic Infantile Dermatitis

Drugs & Therapeutics for Seborrheic Infantile Dermatitis

Drugs for Seborrheic Infantile Dermatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 68)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ciclopirox Approved, Investigational Phase 4 29342-05-0 2749
2
Ketoconazole Approved, Investigational Phase 4 65277-42-1, 142128-57-2 47576 3823 638701
3
Tacrolimus Approved, Investigational Phase 4 104987-11-3 6473866 445643
4
Petrolatum Approved, Investigational Phase 4 8009-03-8
5
Isotretinoin Approved, Investigational, Nutraceutical Phase 4 302-79-4, 4759-48-2 5538 444795 5282379
6
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 5280453
7 Emollients Phase 4
8 Dermatologic Agents Phase 4
9 Hormones Phase 4
10 Hormone Antagonists Phase 4
11 Cytochrome P-450 Enzyme Inhibitors Phase 4
12 Cytochrome P-450 CYP3A Inhibitors Phase 4
13 Calcineurin Inhibitors Phase 4
14 Immunosuppressive Agents Phase 4
15 Vasoconstrictor Agents Phase 4
16 Calcium, Dietary Phase 4
17
Calcium Nutraceutical Phase 4 7440-70-2 271
18
Pimecrolimus Approved, Investigational Phase 2, Phase 3 137071-32-0 17753757 6509979
19
Clobetasol Approved, Experimental, Investigational Phase 3 25122-46-7, 25122-41-2 2791 5311051 32798
20 Anti-Inflammatory Agents Phase 2, Phase 3
21 Antirheumatic Agents Phase 2, Phase 3
22 Anti-Inflammatory Agents, Non-Steroidal Phase 2, Phase 3
23 Analgesics, Non-Narcotic Phase 2, Phase 3
24 Analgesics Phase 2, Phase 3
25 Sunscreening Agents Phase 2, Phase 3
26 glucocorticoids Phase 3
27
Azelaic acid Approved Phase 2 123-99-9 2266
28
Ichthammol Approved Phase 2 8029-68-3
29
Acetylcholine Approved, Investigational Phase 1 51-84-3 187
30 Neurotransmitter Agents Phase 1
31 Botulinum Toxins Phase 1
32 Cholinergic Agents Phase 1
33
Hydrocortisone succinate Approved 2203-97-6 3643
34
Hydrocortisone acetate Approved, Vet_approved 50-03-3
35
Hydrocortisone Approved, Vet_approved 50-23-7 3640 5754
36
Aminolevulinic acid Approved Early Phase 1 106-60-5 137
37
Allantoin Approved 97-59-6 204
38
Triclosan Approved, Investigational 3380-34-5 5564
39
Coal tar Approved 8007-45-2
40
Miconazole Approved, Investigational, Vet_approved 22916-47-8 4189
41
Clotrimazole Approved, Vet_approved 23593-75-1 2812
42
Selenium Approved, Investigational, Vet_approved 7783-07-5, 7782-49-2 533
43
Salicylic acid Approved, Investigational, Vet_approved 69-72-7 338
44
Cholecalciferol Approved, Nutraceutical, Vet_approved 67-97-0, 1406-16-2 5280795 10883523
45 Hydrocortisone 17-butyrate 21-propionate
46 Photosensitizing Agents Early Phase 1
47 Gelatin Sponge, Absorbable
48 Antimetabolites
49 Hypolipidemic Agents
50 Anti-Infective Agents, Local

Interventional clinical trials:

(show all 36)
# Name Status NCT ID Phase Drugs
1 Clinical, Laboratorial and Quality of Life Trial to Evaluate the Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea. Unknown status NCT01139749 Phase 4 oral isotretinoin;salicylic acid and ciclopirox olamine
2 A Double Blind, Placebo-Controlled, Pilot Study to Estimate the Efficacy and Tolerability of Twice Daily Promiseb Topical Cream in Pediatric Subjects With Cradle Cap (Seborrheic Dermatitis) Completed NCT01214434 Phase 4
3 A PHASE 4, OPEN-LABEL STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2% IN THE TREATMENT OF SEBORRHEIC DERMATITIS Completed NCT00703846 Phase 4 Ketoconazole
4 Phase 4 Study of Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis Completed NCT01591070 Phase 4 Tacrolimus
5 A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis Completed NCT03567980 Phase 4 Crisaborole
6 A Double Blind Randomized Trial, Placebo-controled of 0.0003% Calcitriol Ointment Versus 0.1% Tacrolimus Ointment in the Treatment of Pityriasis Alba Completed NCT01388517 Phase 4 Tacrolimus;Calcitriol;Petrolatum
7 Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba: A Randomized Placebo-controlled Trial Unknown status NCT03834935 Phase 2, Phase 3 Elidel (pimecrolimus 1%);Cold Cream
8 Efficacy and Safety of Clobetasol Propionate Shampoo 0.05% Used in Association With an Antifungal Shampoo in the Treatment of Moderate to Severe Scalp Seborrheic Dermatitis Completed NCT00862654 Phase 3 clobetasol propionate shampoo (4/week) - ketoconazole shampoo (2/week);clobetasol propionate shampoo (2/week) - ketoconazole shampoo (2/week);clobetasol propionate shampoo (2/week);ketoconazole shampoo (2/week)
9 Phase 3 : Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis on Adult Face Completed NCT02004860 Phase 3 Protopic (R);Mycoster (R)
10 A Phase 3, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-154 Foam 0.3% Administered QD in Subjects With Seborrheic Dermatitis Completed NCT04973228 Phase 3 ARQ-154 - Active;ARQ-154 Vehicle
11 Efficacy and Safety of ASF 1057 Cream 0.5% in the Treatment of Seborrhoeic Dermatitis: A Phase III Randomised, Double-Blind, Vehicle and Placebo Controlled, Parallel Groups, Multi-Centre Trial. Completed NCT00565279 Phase 3 ASF1057
12 A Phase 2, Randomized, Vehicle and Ketoconazole-Controlled, Evaluator-Blinded, Study to Explore the Efficacy, Pharmacodynamics and Safety of Omiganan 1.75% Topical Gel BID in Patients With Mild to Moderate Facial Seborrheic Dermatitis Unknown status NCT03688971 Phase 2 Omiganan;Ketoconazole;Placebo
13 A Double-Blind, Randomized, Vehicle-Controlled, Six-Week Exploratory Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Seborrheic Dermatitis of the Face Completed NCT00408330 Phase 2 Azelaic Acid 15% Gel;Inactive 15% gel base
14 A Phase 2b, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-154 Foam 0.3% Administered QD in Subjects With Seborrheic Dermatitis Completed NCT04091646 Phase 2 ARQ-154 foam 0.3%;ARQ-154 vehicle foam
15 A Randomized, Double-blind, Single Center, Investigator-initiated Clinical Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Subjects With Mild to Moderate Seborrheic Dermatitis of the Face Completed NCT02749383 Phase 2 PAC-14028 cream 0.3%;PAC-14028 cream 1.0%;PAC-14028 cream vehicle
16 A Parallel-group, Vehicle-controlled, Randomized, Double-blind Study of the Efficacy and Safety of Product 49778 and Product 10156 in Subjects With Seborrheic Dermatitis Completed NCT01703793 Phase 2 Test Product 49778;Test Product 10156;Vehicle (placebo)
17 A 4 Week Randomized Double-blind Parallel Group Active Comparator Controlled Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis Completed NCT00403559 Phase 2 Elidel;Ketoconazole Cream
18 A Phase 2, Multicenter, Open-Label Study of the Long-Term Safety of ARQ-154 Foam 0.3% in Subjects With Seborrheic Dermatitis Completed NCT04445987 Phase 2 ARQ-154
19 The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage in Individuals With Multiple Skin Conditions A Double-Blind, Placebo Controlled Comparative Trial Completed NCT00991198 Phase 2 Topical oxygen;placebo
20 The Efficacy of Sodium Shale Oil Sulponate 1% Shampoo in the Treatment of Pityriasis Capitis Completed NCT02448082 Phase 2
21 Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients Unknown status NCT00767546 Phase 1 Botulinum toxin
22 Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation Unknown status NCT01315951
23 Avaliação da eficácia de um Produto de Uso tópico Contendo Hidrocortisona no Tratamento de Dermatite seborréica na Face. Unknown status NCT01024374
24 Using the SpiderMass(TM) for in Vivo and Real Time Mass Spectrometry Analysis of Subject's Epidermis Suffering From Chronic Inflammatory Dermatosis Compared to Control Groups Unknown status NCT04472546
25 An Open-Label Study of the HairMax LaserComb(r) in the Treatment of Seborrheic Dermatitis of the Scalp. Completed NCT00830908
26 Comparison of Scalp Microbiota of the Patients With Psoriasis Vulgaris and Seborrheic Dermatitis Completed NCT03807453
27 Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis Completed NCT02656368
28 Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis Completed NCT03114111 Early Phase 1 aminolevulinic acid (ALA);Placebo
29 Neurobiology of the Scalp in Seborrheic Dermatitis Completed NCT02349854
30 Multicentric, Randomized, Double Blind Study Under Dermatological Control for Evaluation of the Antidandruff Maintenance Effect of One Shampoo (Reference 1144628 D) Versus Its Vehicle (Reference 1144781) During 8 Weeks After a Ketoconazole-based Antifungal Treatment During 4 Weeks in Adult Subjects (Male and Female) With Light to Moderate Seborrheic Dermatitis Completed NCT04057950
31 Seborrheic Dermatitis of the Scalp in Populations Practicing Less Frequent Hair Washing: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo Completed NCT01203189 ketoconazole 2% foam;ketoconazole 2% shampoo
32 Retrospective Study to Evaluate the Safety of Sebryl® and / or Sebryl Plus® in the Treatment of Seborrheic Dermatitis and Psoriasis of the Scalp in Routine Medical Practice. Completed NCT05105139
33 Cleansing Device for the Treatment of Scalp and Hair Conditions Recruiting NCT05319444
34 Serum 25(OH) Vitamin D and Total Serum Immunoglobulin E Levels in Patients With Pityriasis Alba Active, not recruiting NCT03443765
35 Evaluation of the Efficacy of an Anti Dandruff Shampoo Against Placebo on Dandruff and Scalp Microflora Composition After 4 Weeks of Treatment and 4 Weeks of Relapse Not yet recruiting NCT05506592
36 Evaluation of the Antidandruff Effect of a Shampoo on Subjects With Dandruff and Slight Itching. Single-blind, Monocentric Study Realized Under Dermatological Control Not yet recruiting NCT05503706

Search NIH Clinical Center for Seborrheic Infantile Dermatitis

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Betamethasone
Betamethasone acetate
Betamethasone benzoate
betamethasone dipropionate
betamethasone sodium phosphate
Betamethasone valerate
BETAMETHASONE VALERATE PWDR
chloroxine
Coal Tar
Coal tar extract
Coal tar pitch volatiles
COAL TAR,COLLOIDAL
COAL TAR,REFINED
Colloid sulfur
Ketoconazole
Salicylic Acid
SALICYLIC ACID PWDR
selenium sulfide
Sulfacetamide
Sulfacetamide Sodium
Sulfur
SULFUR PWDR
SULFUR,COLLOIDAL
zinc pyrithione

Cochrane evidence based reviews: dandruff

Genetic Tests for Seborrheic Infantile Dermatitis

Anatomical Context for Seborrheic Infantile Dermatitis

Organs/tissues related to Seborrheic Infantile Dermatitis:

MalaCards : Skin, Liver

Publications for Seborrheic Infantile Dermatitis

Articles related to Seborrheic Infantile Dermatitis:

(show top 50) (show all 135)
# Title Authors PMID Year
1
From the Cochrane Library: Interventions for infantile seborrheic dermatitis (including cradle cap). 62
34571061 2022
2
An Overview of the Diagnosis and Management of Seborrheic Dermatitis. 62
35967915 2022
3
Cholinergic crisis caused by ingesting topical carpronium chloride solution: A case report. 62
34030906 2021
4
Not 'just cradle cap'. 62
34902890 2021
5
Not 'just cradle cap'. 62
34902887 2021
6
Response to "Pityriasis capitis: Causes, pathophysiology, current modalities, and future approach". 62
33314553 2021
7
An Infant With Seborrhoeic Dermatitis and Eczema Herpeticum Complicated by a Generalized Infection. 62
34522478 2021
8
Treatment of cradle cap in infants with a new cosmetic non-steroidal gel cream: Clinical, laboratory, and instrumental evaluation. 62
33934474 2021
9
Pityriasis capitis: Causes, pathophysiology, current modalities, and future approach. 62
32416039 2021
10
Cutaneous disorders of adolescence among Nigerian secondary school students. 62
32774612 2020
11
Seborrhea herpeticum: cutaneous herpes simplex virus infection within infantile seborrheic dermatitis. 62
31886781 2019
12
Interventions for infantile seborrhoeic dermatitis (including cradle cap). 62
30828791 2019
13
Recurrent Vulvar Ulcers and "Cradle Cap" in a 2-Year-Old. 62
30322698 2019
14
Seborrheic Dermatitis in Skin of Color: Clinical Considerations 62
30681789 2019
15
A systematic literature review of the human skin microbiome as biomarker for dermatological drug development. 62
29877593 2018
16
The efficacy of a pseudo-ceramide and eucalyptus extract containing lotion on dry scalp skin. 62
29670385 2018
17
Infantile seborrheic dermatitis: a pediatric Siddha medicine treatise. 62
25889138 2015
18
Topical, Non-Medicated LOYON(®) in Facilitating the Removal of Scaling in Infants and Children with Cradle Cap: a Proof-of-Concept Pilot Study. 62
25119137 2014
19
A clinical and statistical survey of cutaneous changes in the first 120 hours of life. 62
25484382 2014
20
Re: 'Cradle cap' in puppies. 62
24852825 2014
21
Cradle cap. 62
24986302 2014
22
Retrospective analysis of the relationship between infantile seborrheic dermatitis and atopic dermatitis. 62
24224924 2014
23
Improving the management of seborrhoeic dermatitis. 62
24689165 2014
24
Utilization of matrix-assisted laser desorption and ionization time-of-flight mass spectrometry for identification of infantile seborrheic dermatitis-causing Malassezia and incidence of culture-based cutaneous Malassezia microbiota of 1-month-old infants. 62
24387229 2014
25
'Cradle cap' in puppies? 62
24289188 2014
26
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. 62
23806151 2013
27
A double-blind, placebo-controlled pilot study to estimate the efficacy and tolerability of a nonsteroidal cream for the treatment of cradle cap (seborrheic dermatitis). 62
23652893 2013
28
Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences. 62
24146467 2013
29
The LINA cohort: indoor chemical exposure, circulating eosinophil/basophil (Eo/B) progenitors and early life skin manifestations. 62
22925320 2012
30
Randomized, double-blind, split-side comparison study of moisturizer containing licochalcone vs. 1% hydrocortisone in the treatment of infantile seborrhoeic dermatitis. 62
21790793 2012
31
Mucocutaneous disorders in children with down syndrome: case-controlled study. 62
22303799 2011
32
A new postulate on two stages of dandruff: a clinical perspective. 62
21769228 2011
33
Olive oil for cradle cap? 62
21121479 2010
34
Erythroderma in children. 62
20657113 2010
35
The spectrum of skin disease among Indian children. 62
19250398 2009
36
Central serous chorioretinopathy associated with unusual routes of steroid administration. 62
25390854 2009
37
Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance. 62
18058612 2007
38
Management of infantile seborrheic dermatitis. 62
17390592 2007
39
Clinical inquiries. What's the best treatment for cradle cap? 62
17343816 2007
40
On top of cradle cap. 62
17824212 2007
41
Infantile seborrheic dermatitis. 62
16776285 2006
42
The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff. 62
16382662 2005
43
Malassezia furfur in infantile seborrheic dermatitis. 62
16252839 2005
44
Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis. 62
16083165 2004
45
Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole. 62
15241887 2004
46
Should we treat infantile seborrhoeic dermatitis with topical antifungals or topical steroids? 62
14977719 2004
47
Seborrheic dermatitis. 62
14678527 2004
48
The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). 62
12622623 2003
49
Cutaneous lesions in new born. 62
17656992 2002
50
[Seborrheic dermatitis of infancy]. 62
12416520 2002

Variations for Seborrheic Infantile Dermatitis

Expression for Seborrheic Infantile Dermatitis

Search GEO for disease gene expression data for Seborrheic Infantile Dermatitis.

Pathways for Seborrheic Infantile Dermatitis

GO Terms for Seborrheic Infantile Dermatitis

Biological processes related to Seborrheic Infantile Dermatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of epithelial to mesenchymal transition GO:0010719 9.26 ZNF750 IL17RD
2 establishment of skin barrier GO:0061436 8.8 PNPLA1 FLG

Molecular functions related to Seborrheic Infantile Dermatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 structural constituent of skin epidermis GO:0030280 9.26 PNPLA1 FLG
2 interleukin-17 receptor activity GO:0030368 8.92 IL17RE IL17RD

Sources for Seborrheic Infantile Dermatitis

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....